D.A. Davidson & Co’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-400
| Closed | -$4K | – | 2599 |
|
|
2016
Q4 | $4K | Hold |
400
| – | – | ﹤0.01% | 2303 |
|
|
2016
Q3 | $5K | Hold |
400
| – | – | ﹤0.01% | 2206 |
|
|
2016
Q2 | $2K | Hold |
400
| – | – | ﹤0.01% | 2265 |
|
|
2016
Q1 | $2K | Hold |
400
| – | – | ﹤0.01% | 2182 |
|
|
2015
Q4 | $2K | Hold |
400
| – | – | ﹤0.01% | 2157 |
|
|
2015
Q3 | $2K | Hold |
400
| – | – | ﹤0.01% | 2119 |
|
|
2015
Q2 | $3K | Hold |
400
| – | – | ﹤0.01% | 2094 |
|
|
2015
Q1 | $3K | Hold |
400
| – | – | ﹤0.01% | 1986 |
|
|
2014
Q4 | $2K | Hold |
400
| – | – | ﹤0.01% | 2044 |
|
|
2014
Q3 | $2K | Hold |
400
| – | – | ﹤0.01% | 2059 |
|
|
2014
Q2 | $2K | Hold |
400
| – | – | ﹤0.01% | 2048 |
|
|
2014
Q1 | $3K | Buy |
400
+335
| +515% | +$2.61K | ﹤0.01% | 2015 |
|
|
2013
Q4 | $0 | Sell |
65
-7,826
| -99% | -$42.3K | ﹤0.01% | 2167 |
|
|
2013
Q3 | $144K | Sell |
7,891
-41
| -0.5% | -$796 | 0.01% | 791 |
|
|
2013
Q2 | $138K | Buy |
+7,932
| New | +$141K | 0.01% | 773 |
|
Other funds holding ARIA
D.A. Davidson & Co's ARIA Position: Q1 2017 in Review
D.A. Davidson & Co sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 400 shares — an estimated $4K sold.
D.A. Davidson & Co first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $144K in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- D.A. Davidson & Co reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- D.A. Davidson & Co sold 400 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $4K.
- D.A. Davidson & Co first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
- D.A. Davidson & Co's Ariad Pharmaceuticals Inc position peaked at $144K in Q3 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on D.A. Davidson & Co's 13F filing for Q1 2017, filed 12 May 2017.